# Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

> **NCT07267949** · PHASE2 · RECRUITING · sponsor: **Acesion Pharma** · enrollment: 200 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **DRUG:** AP31969
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07267949
- **Lead sponsor:** Acesion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-22
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07267949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07267949, "Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT07267949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*